Cargando…
New Therapeutic Strategies for Lung Cancer
Autores principales: | Icard, Philippe, Damotte, Diane, Alifano, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072685/ https://www.ncbi.nlm.nih.gov/pubmed/33923765 http://dx.doi.org/10.3390/cancers13081937 |
Ejemplares similares
-
Prognostic value of LIPC in non-small cell lung carcinoma
por: Alifano, Marco, et al.
Publicado: (2013) -
How Phosphofructokinase-1 Promotes PI3K and YAP/TAZ in Cancer: Therapeutic Perspectives
por: Simula, Luca, et al.
Publicado: (2022) -
Pre-Disease and Pre-Surgery BMI, Weight Loss and Sarcopenia Impact Survival of Resected Lung Cancer Independently of Tumor Stage
por: Icard, Philippe, et al.
Publicado: (2020) -
Twenty-Year Survival of Patients Operated on for Non-Small-Cell Lung Cancer: The Impact of Tumor Stage and Patient-Related Parameters
por: Schussler, Olivier, et al.
Publicado: (2022) -
Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer
por: Alifano, Marco
Publicado: (2020)